These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26225736)

  • 1. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
    Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
    Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing.
    Oliveira AC; Martens TF; Raemdonck K; Adati RD; Feitosa E; Botelho C; Gomes AC; Braeckmans K; Real Oliveira ME
    ACS Appl Mater Interfaces; 2014 May; 6(9):6977-89. PubMed ID: 24712543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells.
    Lopes I; C N Oliveira A; P Sárria M; P Neves Silva J; Gonçalves O; Gomes AC; Real Oliveira ME
    J Liposome Res; 2016 Sep; 26(3):199-210. PubMed ID: 26340109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.
    Silva JP; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
    Colloids Surf B Biointerfaces; 2014 Sep; 121():371-9. PubMed ID: 25023903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DODAB:monoolein-based lipoplexes as non-viral vectors for transfection of mammalian cells.
    Silva JP; Oliveira AC; Casal MP; Gomes AC; Coutinho PJ; Coutinho OP; Oliveira ME
    Biochim Biophys Acta; 2011 Oct; 1808(10):2440-9. PubMed ID: 21787746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
    Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR
    Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
    Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
    Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes: effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases.
    Silva JP; Oliveira IM; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
    Biochim Biophys Acta; 2014 Oct; 1838(10):2555-67. PubMed ID: 24976292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
    Berger M; Toussaint F; Djemaa SB; Laloy J; Pendeville H; Evrard B; Jerôme C; Lechanteur A; Mottet D; Debuigne A; Piel G
    J Control Release; 2023 Sep; 361():87-101. PubMed ID: 37482343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis.
    Carneiro C; Correia A; Lima T; Vilanova M; Pais C; Gomes AC; Real Oliveira MECD; Sampaio P
    Acta Biomater; 2016 Jul; 39():133-145. PubMed ID: 27150234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
    Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(N-methyl-N-vinylacetamide): A Strong Alternative to PEG for Lipid-Based Nanocarriers Delivering siRNA.
    Berger M; Toussaint F; Ben Djemaa S; Maquoi E; Pendeville H; Evrard B; Jerôme C; Leblond Chain J; Lechanteur A; Mottet D; Debuigne A; Piel G
    Adv Healthc Mater; 2024 Mar; 13(8):e2302712. PubMed ID: 37994483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diffusion-driven microfluidic process to manufacture lipid-based nanotherapeutics with stealth properties for siRNA delivery.
    Eş I; Malfatti-Gasperini AA; de la Torre LG
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112476. PubMed ID: 35390597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP; Altin JG
    J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.